mifepristone has been researched along with tacrolimus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baulieu, EE; Delespierre, B; Jung-Testas, I | 1 |
| Baulieu, EE; Catelli, MG; Jung-Testas, I; Lebeau, MC | 1 |
| Aziz, S; Butt, TR; Graumann, K | 1 |
| Haehner, T; Müller-Enoch, D; Refaie, MO | 1 |
| Avram, D; Berchtold, S; Drews, G; Düfer, M; Lang, F; Ranta, F; Ullrich, S | 1 |
| Crotti, TN; Faralli, JA; Filla, MS; Gagen, D; Peters, DM | 1 |
| Carolan, JP; Cruz-Rodríguez, O; Højfeldt, JW; Imaeda, Y; Iñiguez-Lluhí, JA; Mapp, AK; Van Dyke, AR | 1 |
1 review(s) available for mifepristone and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for mifepristone and tacrolimus
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]].
Topics: Animals; Cell Division; Cells, Cultured; Dexamethasone; Fibroblasts; Mice; Mifepristone; Tacrolimus | 1993 |
Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant.
Topics: Animals; Cells, Cultured; Cyclosporine; Cytoplasm; Fibroblasts; Immunosuppressive Agents; Mice; Mifepristone; Mutation; Polyenes; Rabbits; Receptors, Progesterone; Sirolimus; Tacrolimus; Time Factors | 1995 |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506.
Topics: beta-Galactosidase; Carrier Proteins; DNA-Binding Proteins; Gene Deletion; Heat-Shock Proteins; Hormone Antagonists; Humans; Immunosuppressive Agents; Mifepristone; Progesterone; Receptors, Progesterone; Recombinant Proteins; Saccharomyces cerevisiae; Tacrolimus; Tacrolimus Binding Proteins; Transcription, Genetic | 1996 |
Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system.
Topics: Antifungal Agents; Antimalarials; Catalysis; Chromatography, High Pressure Liquid; Cimetidine; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Estrogen Antagonists; Ethinyl Estradiol; Flavanones; Hormone Antagonists; Humans; Immunosuppressive Agents; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Mifepristone; NADPH-Ferrihemoprotein Reductase; Phospholipids; Quinidine; Quinine; Tacrolimus | 2004 |
Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4.
Topics: Animals; Cell Line; Dexamethasone; Exenatide; Humans; Insecticides; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Lizards; Mice; Microscopy, Fluorescence; Mifepristone; Nitriles; Peptides; Pyrethrins; Tacrolimus; Venoms | 2006 |
Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway.
Topics: Calcineurin; Cell Line; Cycloheximide; Cyclosporine; Dexamethasone; Ethanol; Half-Life; Humans; Integrin alphaVbeta3; Mifepristone; NFATC Transcription Factors; Receptors, Glucocorticoid; RNA Stability; RNA, Messenger; Signal Transduction; Tacrolimus; Trabecular Meshwork | 2013 |
Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor.
Topics: Calcium-Binding Proteins; Dexamethasone; HEK293 Cells; Histone Deacetylase 1; Humans; Ligands; Mifepristone; Neoplasm Proteins; Protein Binding; Receptors, Glucocorticoid; Tacrolimus; Transcriptional Activation | 2014 |